Myriem Tamimy, elected president of the association of drug companies in Morocco

The association “Medicine companies in Morocco” announces, this Tuesday, November 22, that its members have elected a new executive office during its general assembly.

November 22, 2022 at 2:15 p.m.

Modified November 22, 2022 at 2:41 p.m.

The association “Medicine companies in Morocco” announces, this Tuesday, November 22, that its members have elected a new executive office during its general assembly.

“For the first time, a Moroccan will represent the international biopharmaceutical sector”, highlights a press release from the association “Medicine companies in Morocco” (LEMM). The composition of the new board is as follows:

– President: Myriem Tamimy, general manager of the company GSK ;

– Vice-presidents: companies Roche, Sanofi and MSD represented by their managing directors, respectively Sanaa Sayagh, Amine Benabderrazik and Alain Barry;

– General Secretary: Mehdi Seqat, General Manager of the company Janssen ;

– Treasurer: Amine Sekhri, CEO ofAstraZeneca ;

– Finally, the executive director is Fadela Benjelloun.

LEMM is a professional association bringing together 18 active members, Moroccan subsidiaries of international pharmaceutical groups.

November 22, 2022 at 2:15 p.m.

Modified November 22, 2022 at 2:41 p.m.